Spero Therapeutics, Inc. SPRO Q1 2026 earnings

FAQ

When did Spero Therapeutics, Inc. report Q1 2026 earnings?

Spero Therapeutics, Inc. (SPRO) reported Q1 2026 earnings on May 13, 2026 after market close.

What were Spero Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Spero Therapeutics, Inc. reported revenue of $258.0K and eps of $-0.13 for Q1 2026.

Did Spero Therapeutics, Inc. beat estimates in Q1 2026?

Revenue beat the consensus estimate of $258.0K by -. EPS beat the consensus estimate of $-0.18 by $0.05.

How did Spero Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 95.6% from $5.9M a year earlier and eps grew 48.0% from $-0.25.

Where can I find Spero Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-221567) and the 10-Q periodic report (0001193125-26-221591) directly on SEC EDGAR. The filing index links above go to sec.gov.